Resources
Publications

Rationale, Application and Clinical Qualification for NT-proBNP as a Surrogate End Point

Published: Leukemia, July 2016 | Author: G Merlini et al.

AMYLOIDOSIS RESEARCH CONSORTIUM, INC.
320 Nevada Street, Suite 210 Newton, MA 02460 USA | 617-467-5170
22 (G1) FORTH STREET, EDINBURGH, UK EH1 3LH | +44 (0) 131 550 3866
arc@arci.org

ARC is a 501(c)(3) nonprofit organization